SCHEMBL8916855

SCHEMBL8916855

CC(C)=CCCC(C)=CCC(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.56
FNTB P49356 1/20 0.56
GGPS1 O95749 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5400265 1.00 FNTA (0.56) FNTAFNTBGGPS1
SCHEMBL8916847 1.00 FNTA (0.56) FNTAFNTBGGPS1
SCHEMBL16079902 0.98 FNTA (0.59) FNTAFNTBGGPS1
SCHEMBL8916061 0.98 FNTA (0.59) FNTAFNTBGGPS1
SCHEMBL2875241 0.98 FNTA (0.59) FNTAFNTBGGPS1
SCHEMBL9127288 0.93 FNTA (0.53) FNTAFNTBGGPS1
SCHEMBL9128237 0.91 FNTA (0.56) FNTAFNTBGGPS1
SCHEMBL2697221 0.91 FNTA (0.56) FNTAFNTBGGPS1
SCHEMBL8390164 0.86 FNTA (0.50) FNTA
SCHEMBL9633689 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513761-A2 Bisphosphonate squalene synthetase inhibitors E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP claimed
US-5157027-A Anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1992-10-20 US claimed
US-5624917-A Method of inhibiting squalene synthetase TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-04-29 US disclosed
EP-0541037-A2 Squalene synthetase inhibitory composition and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-05-12 EP disclosed
EP-0513761-A2 Bisphosphonate squalene synthetase inhibitors E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP disclosed
US-5157027-A Anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1992-10-20 US disclosed